Glu[Cyclo(Arg-Gly-Asp-D-Phe-Lys)]2
H-E[cyclo(RGDfK)]2
H-Glu[cyclo(Arg-Gly-Asp-D-Phe-Lys)]2
3438-v 1 mg | 195.00 EUR
| (M.W. 1318.4) | C59H87N19 O16 S |
Synthetic Product
Purity: ≧95.0% (HPLC), Solubility: H2O (1 mM)
Tumor-Targeting Dimeric Cyclic RGD Peptide
References:
- M.L. Janssen, W.J. Oyen, I. Dijkgraaf, L.F. Massuger, C. Frielink, D.S. Edwards, M. Rajopadhye, H. Boonstra, F.H. Corstens and O.C. Boerman, Cancer Res. , 62, 6146 (2002)
- Y. Wu, X.Z. Zhang, Z.M. Xiong, Z. Cheng, D.R. Fisher, S. Liu, S.S. Gambhir and X.Y. Chen, J. Nucl. Med., 46, 1707 (2005)
For Laboratory use only! Not for Drug Use!
